Company Filing History:
Years Active: 2012-2013
Title: Xilian Yue: Innovator in Cell Therapy
Introduction
Xilian Yue is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cell therapy, particularly through his innovative patents. With a total of 2 patents, Yue's work focuses on the preparation and application of artificial antigen presenting cells.
Latest Patents
Yue's latest patents include methods for processing inactivated artificial antigen presenting cells (aAPCs). These aAPCs are designed to have specificity for selected antigenic peptides. The patents describe their generation and use in cell therapy compositions that comprise activated cytotoxic T lymphocytes. Notably, inactivated aAPCs are generated through crosslinking, utilizing a photoreaction involving a psoralen derivative and UVA irradiation.
Career Highlights
Xilian Yue is currently employed at Janssen Pharmaceutica NV, where he continues to advance his research in cell therapies. His work has the potential to significantly impact the treatment of various diseases by enhancing the effectiveness of immune responses.
Collaborations
Yue collaborates with esteemed colleagues, including Zeling Cai and Ann M Moriarty. These partnerships foster a dynamic research environment that encourages innovation and the development of new therapeutic strategies.
Conclusion
Xilian Yue's contributions to the field of cell therapy through his patents and collaborations highlight his role as a key innovator. His work promises to advance the understanding and application of artificial antigen presenting cells in medical therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.